Today Westlaw
Published November 16, 2026 · Updated November 17, 2026
Helus psychedelic depression drug succeeds in trial amid safety scrutiny - Westlaw Today
Read the full story at Today Westlaw
Nov 16 (Reuters) - Helus Pharma said on Monday its experimental psychedelic drug significantly improved depression symptoms in a late-stage trial.
Surfaced by 5 Google Alerts
- Psychedelics
- Psychedelic crime
- Gray market psychedelics
- Psychedelic biotech
- Magic mushrooms